Clinical Trial Update: Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation and expansion study of WTX-124 as monotherapy and in combination with pembrolizumab in selected advanced or metastatic solid tumors; sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• WTX-124

Snippet

Sponsor: Werewolf Therapeutics, Inc. | Conditions: Metastatic Solid Tumor, Advanced Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING